activins has been researched along with Autoimmune Diabetes in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwata, H; Liu, X; Takemoto, N; Takii, K; Teramura, Y | 1 |
de Heer, E; de Vinuesa, AG; Fog-Tonnesen, M; Høj Thomsen, L; Krarup Hansen, T; Nielsen Fink, L; Norlin, J; Rosendahl, A; Ten Dijke, P | 1 |
de Kretser, DM; Hammes, HP; Hedger, MP; Linn, T; Ludlow, H; Maresch, CC; Stute, DC | 1 |
Elefanty, AG; Holland, AM; Stanley, EG | 1 |
Raikwar, SP; Zavazava, N | 1 |
Stainier, D | 1 |
Chan, KM; Raikwar, SP; Zavazava, N | 1 |
1 review(s) available for activins and Autoimmune Diabetes
Article | Year |
---|---|
Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence.
Topics: Activins; Animals; Cell Differentiation; Diabetes Mellitus, Type 1; Diagnostic Imaging; Embryonic Stem Cells; Endoderm; Humans; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Luciferases; Stem Cell Transplantation; Transcription Factors | 2007 |
6 other study(ies) available for activins and Autoimmune Diabetes
Article | Year |
---|---|
Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression.
Topics: Activins; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Graft Survival; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Liver; Liver Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Portal Vein; Sertoli Cells | 2014 |
Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
Topics: Activins; Adult; Aged; Aged, 80 and over; Animals; Bone Morphogenetic Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epithelial Cells; Female; Humans; Kidney Tubules; Male; Mice; Mice, 129 Strain; Middle Aged; Models, Biological; Phosphorylation; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta; Up-Regulation | 2017 |
Hyperglycemia is associated with reduced testicular function and activin dysregulation in the Ins2
Topics: Activins; Animals; Blood Glucose; Body Weight; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Follistatin; Hyperglycemia; Inflammation Mediators; Insulin; Male; Mice, Inbred C57BL; Organ Size; Real-Time Polymerase Chain Reaction; Testis | 2017 |
Pancreatic differentiation from pluripotent stem cells: tweaking the system.
Topics: Activins; Androstadienes; Cell Differentiation; Diabetes Mellitus, Type 1; Embryonic Stem Cells; Epidermal Growth Factor; Humans; Insulin-Secreting Cells; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pluripotent Stem Cells; Transforming Growth Factor beta; Wortmannin | 2009 |
Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells corrects hyperglycemia in diabetic mice.
Topics: Activins; Animals; Cell Culture Techniques; Cell Differentiation; Diabetes Mellitus, Type 1; Embryonic Stem Cells; Endoderm; Homeodomain Proteins; Hyperglycemia; Insulin-Secreting Cells; Mice; Pancreas; Promoter Regions, Genetic; Receptors, CXCR4; Trans-Activators; Treatment Outcome | 2011 |
No stem cell is an islet (yet).
Topics: Activins; Animals; Cell Differentiation; Diabetes Mellitus, Type 1; Embryo, Mammalian; Endoderm; Humans; Inhibin-beta Subunits; Insulin-Secreting Cells; Receptors, CXCR4; Stem Cells | 2006 |